| Product Code: ETC9941529 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Congenital Heart Disease Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Congenital Heart Disease Market - Industry Life Cycle |
3.4 United Kingdom (UK) Congenital Heart Disease Market - Porter's Five Forces |
3.5 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.10 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Congenital Heart Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of congenital heart disease in the UK |
4.2.2 Technological advancements in diagnostic and treatment options |
4.2.3 Rising awareness about congenital heart disease among healthcare professionals and patients |
4.3 Market Restraints |
4.3.1 High treatment costs associated with congenital heart disease |
4.3.2 Limited availability of specialized healthcare facilities for treating congenital heart disease patients in some regions |
4.3.3 Stringent regulatory requirements for approval of new treatments and devices |
5 United Kingdom (UK) Congenital Heart Disease Market Trends |
6 United Kingdom (UK) Congenital Heart Disease Market, By Types |
6.1 United Kingdom (UK) Congenital Heart Disease Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Heart Valve Defects, 2021- 2031F |
6.1.4 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Heart Wall Defects, 2021- 2031F |
6.1.5 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Blood Vessel Defects, 2021- 2031F |
6.1.6 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Congenital Heart Disease Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Electrocardiogram, 2021- 2031F |
6.2.3 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Chest X-ray, 2021- 2031F |
6.2.4 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Echocardiogram, 2021- 2031F |
6.2.5 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Transoesophageal Echocardiogram, 2021- 2031F |
6.2.6 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Pulse Oximetry, 2021- 2031F |
6.2.7 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Exercise Stress Test, 2021- 2031F |
6.2.8 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Cardiac Catheterization, 2021- 2031F |
6.2.9 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Cardiac Catheterization, 2021- 2031F |
6.3 United Kingdom (UK) Congenital Heart Disease Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Medications, 2021- 2031F |
6.3.3 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3.4 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Watchful Waiting, 2021- 2031F |
6.3.5 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Congenital Heart Disease Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United Kingdom (UK) Congenital Heart Disease Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United Kingdom (UK) Congenital Heart Disease Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 United Kingdom (UK) Congenital Heart Disease Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Congenital Heart Disease Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Congenital Heart Disease Market Export to Major Countries |
7.2 United Kingdom (UK) Congenital Heart Disease Market Imports from Major Countries |
8 United Kingdom (UK) Congenital Heart Disease Market Key Performance Indicators |
8.1 Average age at which congenital heart disease is diagnosed in the UK |
8.2 Number of healthcare professionals specializing in congenital heart disease |
8.3 Adoption rate of new technologies and treatment modalities for congenital heart disease |
9 United Kingdom (UK) Congenital Heart Disease Market - Opportunity Assessment |
9.1 United Kingdom (UK) Congenital Heart Disease Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Congenital Heart Disease Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 United Kingdom (UK) Congenital Heart Disease Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 United Kingdom (UK) Congenital Heart Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 United Kingdom (UK) Congenital Heart Disease Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.6 United Kingdom (UK) Congenital Heart Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Congenital Heart Disease Market - Competitive Landscape |
10.1 United Kingdom (UK) Congenital Heart Disease Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Congenital Heart Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here